Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Globus Medical
GMED
Globus Medical
Aging Demographics And Robotics Integration Will Support Secular Trends
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
11 May 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$105.00
44.1% undervalued
intrinsic discount
08 Aug
US$58.65
Loading
1Y
-19.7%
7D
9.4%
Author's Valuation
US$105.0
44.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$105.0
44.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
4b
2014
2017
2020
2023
2025
2026
2028
Revenue US$3.5b
Earnings US$666.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.12%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.50%
Calculation
US$666.56m
Earnings '28
x
26.41x
PE Ratio '28
=
US$17.60b
Market Cap '28
US$17.60b
Market Cap '28
/
135.30m
No. shares '28
=
US$130.11
Share Price '28
US$130.11
Share Price '28
Discounted to 2025 @ 7.49% p.a.
=
US$104.77
Fair Value '25